{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:37:32Z","timestamp":1790228252907,"version":"4.1.0"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,7,1]]},"DOI":"10.1248\/bpb.b21-00218","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T22:07:47Z","timestamp":1619215667000},"page":"984-991","source":"Crossref","is-referenced-by-count":26,"title":["Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood\u2013Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines"],"prefix":"10.1248","volume":"44","author":[{"given":"Keita","family":"Kitamura","sequence":"first","affiliation":[{"name":"Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University"},{"name":"Laboratory of Clinical Pharmacy & Experimental Therapeutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Umehara","sequence":"additional","affiliation":[{"name":"Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ito","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, Ono Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Yamaura","sequence":"additional","affiliation":[{"name":"Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Komori","sequence":"additional","affiliation":[{"name":"Drug Metabolism and Pharmacokinetics Tsukuba, Tsukuba Research Laboratories, Eisai Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Morio","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacy & Experimental Therapeutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Akita","sequence":"additional","affiliation":[{"name":"Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Furihata","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacy & Experimental Therapeutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Banks WA. From blood-brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery. Nat. Rev. Drug Discov.<\/i>, 15<\/b>, 275\u2013292 (2016).","DOI":"10.1038\/nrd.2015.21"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Abbott NJ. Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery. J. Inherit. Metab. Dis.<\/i>, 36<\/b>, 437\u2013449 (2013).","DOI":"10.1007\/s10545-013-9608-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pardridge WM. Blood\u2013brain barrier delivery. Drug Discov. Today<\/i>, 12<\/b>, 54\u201361 (2007).","DOI":"10.1016\/j.drudis.2006.10.013"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood\u2013brain barrier in health and disease. Acta Neuropathol.<\/i>, 135<\/b>, 311\u2013336 (2018).","DOI":"10.1007\/s00401-018-1815-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Zlokovic BV. The blood\u2013brain barrier in health and chronic neurodegenerative disorders. Neuron<\/i>, 57<\/b>, 178\u2013201 (2008).","DOI":"10.1016\/j.neuron.2008.01.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol.<\/i>, 14<\/b>, 133\u2013150 (2018).","DOI":"10.1038\/nrneurol.2017.188"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pardridge W. The bloodbrain barrier: bottleneck in brain drug development. NeuroRx<\/i>, 2<\/b>, 3\u201314 (2005).","DOI":"10.1602\/neurorx.2.1.3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shechter R, London A, Schwartz M. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus<\/i> educational gates. Nat. Rev. Immunol.<\/i>, 13<\/b>, 206\u2013218 (2013).","DOI":"10.1038\/nri3391"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat. Rev. Immunol.<\/i>, 17<\/b>, 761\u2013773 (2017).","DOI":"10.1038\/nri.2017.100"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lopes Pinheiro MA, Kooij G, Mizee MR, Kamermans A, Enzmann G, Lyck R, Schwaninger M, Engelhardt B, de Vries HE. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Biochim. Biophys. Acta<\/i>, 1862<\/b>, 461\u2013471 (2016).","DOI":"10.1016\/j.bbadis.2015.10.018"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Varvel NH, Neher JJ, Bosch A, Wang W, Ransohoff RM, Miller RJ, Dingledine R. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 113<\/b>, E5665\u2013E5674 (2016).","DOI":"10.1073\/pnas.1604263113"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sivandzade F, Cucullo L. In-vitro<\/i> blood\u2013brain barrier modeling: a review of modern and fast-advancing technologies. J. Cereb. Blood Flow Metab.<\/i>, 38<\/b>, 1667\u20131681 (2018).","DOI":"10.1177\/0271678X18788769"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kaisar MA, Sajja RK, Prasad S, Abhyankar VV, Liles T, Cucullo L. New experimental models of the blood\u2013brain barrier for CNS drug discovery. Expert Opin. Drug Discov.<\/i>, 12<\/b>, 89\u2013103 (2017).","DOI":"10.1080\/17460441.2017.1253676"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Stanimirovic DB, Bani-Yaghoub M, Perkins M, Haqqani AS. Blood-brain barrier models: in vitro<\/i> to in vivo<\/i> translation in preclinical development of CNS-targeting biotherapeutics. Expert Opin. Drug Discov.<\/i>, 10<\/b>, 141\u2013155 (2015).","DOI":"10.1517\/17460441.2015.974545"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) S\u00e1-Pereira I, Brites D, Brito MA. Neurovascular unit: a focus on pericytes. Mol. Neurobiol.<\/i>, 45<\/b>, 327\u2013347 (2012).","DOI":"10.1007\/s12035-012-8244-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Petzold GC, Murthy VN. Role of astrocytes in neurovascular coupling. Neuron<\/i>, 71<\/b>, 782\u2013797 (2011).","DOI":"10.1016\/j.neuron.2011.08.009"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, Tanaka K, Niwa M. A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int.<\/i>, 54<\/b>, 253\u2013263 (2009).","DOI":"10.1016\/j.neuint.2008.12.002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Thomsen LB, Burkhart A, Moos T. A triple culture model of the blood\u2013brain barrier using porcine brain endothelial cells, astrocytes and pericytes. PLOS ONE<\/i>, 10<\/b>, e0134765 (2015).","DOI":"10.1371\/journal.pone.0134765"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ. Development of a three-dimensional, all-human in vitro<\/i> model of the blood\u2013brain barrier using mono-, co-, and tri-cultivation Transwell models. J. Neurosci. Methods<\/i>, 199<\/b>, 223\u2013229 (2011).","DOI":"10.1016\/j.jneumeth.2011.05.012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tetsuka K, Ohbuchi M, Kawabe T, Goto T, Kiyonaga F, Takama K, Yamazaki S, Fujimori A. Reconstituted human organ models as a translational tool for human organ response: definition, expectations, cases, and strategies for implementation in drug discovery and development. Biol. Pharm. Bull.<\/i>, 43<\/b>, 375\u2013383 (2020).","DOI":"10.1248\/bpb.b19-01070"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Cakir B, Xiang Y, Tanaka Y, et al.<\/i> Engineering of human brain organoids with a functional vascular-like system. Nat. Methods<\/i>, 16<\/b>, 1169\u20131175 (2019).","DOI":"10.21203\/rs.2.13464\/v1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Cho CF, Wolfe JM, Fadzen CM, Calligaris D, Hornburg K, Chiocca EA, Agar NYR, Pentelute BL, Lawler SE. Blood\u2013brain-barrier spheroids as an in vitro<\/i> screening platform for brain-penetrating agents. Nat. Commun.<\/i>, 8<\/b>, 15623 (2017).","DOI":"10.1038\/ncomms15623"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ito R, Umehara K, Suzuki S, Kitamura K, Nunoya K, Yamaura Y, Imawaka H, Izumi S, Wakayama N, Komori T, Anzai N, Akita H, Furihata T. A human immortalized cell-based blood\u2013brain barrier triculture model: development and characterization as a promising tool for drug\u2013brain permeability studies. Mol. Pharm.<\/i>, 16<\/b>, 4461\u20134471 (2019).","DOI":"10.1021\/acs.molpharmaceut.9b00519"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Furihata T, Ito R, Kamiichi A, Saito K, Chiba K. Establishment and characterization of a new conditionally immortalized human astrocyte cell line. J. Neurochem.<\/i>, 136<\/b>, 92\u2013105 (2016).","DOI":"10.1111\/jnc.13358"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Umehara K, Sun Y, Hiura S, Hamada K, Itoh M, Kitamura K, Oshima M, Iwama A, Saito K, Anzai N, Chiba K, Akita H, Furihata T. A new conditionally immortalized human fetal brain pericyte cell line: establishment and functional characterization as a promising tool for human brain pericyte studies. Mol. Neurobiol.<\/i>, 55<\/b>, 5993\u20136006 (2018).","DOI":"10.1007\/s12035-017-0815-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Urich E, Patsch C, Aigner S, Graf M, Iacone R, Freskgard PO. Multicellular self-assembled spheroidal model of the blood brain barrier. Sci. Rep.<\/i>, 3<\/b>, 1500 (2013).","DOI":"10.1038\/srep01500"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Bergmann S, Lawler SE, Qu Y, Fadzen CM, Wolfe JM, Regan MS, Pentelute BL, Agar NYR, Cho CF. Blood\u2013brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat. Protoc.<\/i>, 13<\/b>, 2827\u20132843 (2018).","DOI":"10.1038\/s41596-018-0066-x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nzou G, Wicks RT, Wicks EE, Seale SA, Sane CH, Chen A, Murphy SV, Jackson JD, Atala AJ. Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling. Sci Rep<\/i>, 8<\/b>, 7413 (2018).","DOI":"10.1038\/s41598-018-25603-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kitamura K, Ito R, Umehara K, Morio H, Saito K, Suzuki S, Hashimoto M, Saito Y, Anzai N, Akita H, Chiba K, Furihata T. Differentiated HASTR\/ci35 cells: a promising in vitro<\/i> human astrocyte model for facilitating CNS drug development studies. J. Pharmacol. Sci.<\/i>, 137<\/b>, 350\u2013358 (2018).","DOI":"10.1016\/j.jphs.2018.06.013"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood\u2013brain barrier. Nat. Med.<\/i>, 19<\/b>, 1584\u20131596 (2013).","DOI":"10.1038\/nm.3407"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte-endothelial interactions at the blood\u2013brain barrier. Nat. Rev. Neurosci.<\/i>, 7<\/b>, 41\u201353 (2006).","DOI":"10.1038\/nrn1824"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood\u2013brain barrier. Cell<\/i>, 163<\/b>, 1064\u20131078 (2015).","DOI":"10.1016\/j.cell.2015.10.067"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Mahringer A, Fricker G. ABC transporters at the blood\u2013brain barrier. Expert Opin. Drug Metab. Toxicol.<\/i>, 12<\/b>, 499\u2013508 (2016).","DOI":"10.1517\/17425255.2016.1168804"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Banks WA. From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery. Nat. Rev. Drug Discov.<\/i>, 15<\/b>, 275\u2013292 (2016).","DOI":"10.1038\/nrd.2015.21"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat. Rev. Immunol.<\/i>, 17<\/b>, 49\u201359 (2017).","DOI":"10.1038\/nri.2016.123"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/7\/44_b21-00218\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:35:57Z","timestamp":1715142957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/7\/44_b21-00218\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b21-00218","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"b21-00218"}}